Ads

You May Also Like

BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China

BEIJING, China, and CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

Curetis Expects Near-Term FDA Decision on De Novo Request

- Review of the Unyvero System and Lower Respiratory Tract (LRT) Cartridge is nearing completion- ...